Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hollins Communications Research Institute is a Virginia-based nonprofit healthcare and research organization focused on the investigation and treatment of stuttering. Founded in 1972, HCRI developed a proprietary, science-based behavioral stuttering therapy program delivered through intensive 12-day treatment courses at its Roanoke-area center. The institute combines clinician-led therapy with specialized electronic and computer-assisted tools, including the Voice Monitor and web-based support technologies, to help patients acquire and maintain fluent speech. HCRI also conducts stuttering-related research and has participated in high-profile scientific collaborations, including work with the National Institutes of Health on the genetics of stuttering. The organization appears to operate as a specialized speech-language treatment provider rather than a biotech or pharmaceutical drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hollins Communications Research Institute.